These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14663052)

  • 1. Diagnostic value of sural nerve matrix metalloproteinase-9 in diabetic patients with CIDP.
    Jann S; Bramerio MA; Beretta S; Koch S; Defanti CA; Toyka KV; Sommer C
    Neurology; 2003 Dec; 61(11):1607-10. PubMed ID: 14663052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP.
    Sommer C; Koch S; Lammens M; Gabreels-Festen A; Stoll G; Toyka KV
    Neurology; 2005 Dec; 65(12):1924-9. PubMed ID: 16380614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic criteria of chronic inflammatory demyelinating polyneuropathy in diabetes mellitus.
    Lotan I; Hellman MA; Steiner I
    Acta Neurol Scand; 2015 Oct; 132(4):278-83. PubMed ID: 25819084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers of CIDP in patients with diabetes or CMT1.
    Latov N
    J Peripher Nerv Syst; 2011 Jun; 16 Suppl 1():14-7. PubMed ID: 21696491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy.
    Leppert D; Hughes P; Huber S; Erne B; Grygar C; Said G; Miller KM; Steck AJ; Probst A; Fuhr P
    Neurology; 1999 Jul; 53(1):62-70. PubMed ID: 10408538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic inflammatory demyelinating polyradiculoneuropathy: a study of proposed electrodiagnostic and histologic criteria.
    Haq RU; Fries TJ; Pendlebury WW; Kenny MJ; Badger GJ; Tandan R
    Arch Neurol; 2000 Dec; 57(12):1745-50. PubMed ID: 11115240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corneal confocal microscopy differentiates inflammatory from diabetic neuropathy.
    Fleischer M; Lee I; Erdlenbruch F; Hinrichs L; Petropoulos IN; Malik RA; Hartung HP; Kieseier BC; Kleinschnitz C; Stettner M
    J Neuroinflammation; 2021 Apr; 18(1):89. PubMed ID: 33832507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetics.
    Stewart JD; McKelvey R; Durcan L; Carpenter S; Karpati G
    J Neurol Sci; 1996 Oct; 142(1-2):59-64. PubMed ID: 8902721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demyelinating neuropathy in diabetes mellitus.
    Sharma KR; Cross J; Farronay O; Ayyar DR; Shebert RT; Bradley WG
    Arch Neurol; 2002 May; 59(5):758-65. PubMed ID: 12020257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin is effective in patients with diabetes and with chronic inflammatory demyelinating polyneuropathy: long term follow-up.
    Jann S; Bramerio MA; Facchetti D; Sterzi R
    J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):70-3. PubMed ID: 18768571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research criteria for defining patients with CIDP.
    Sander HW; Latov N
    Neurology; 2003 Apr; 60(8 Suppl 3):S8-15. PubMed ID: 12707417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic value of sural nerve T cells in chronic inflammatory demyelinating polyneuropathy.
    Bosboom WM; Van den Berg LH; De Boer L; Van Son MJ; Veldman H; Franssen H; Logtenberg T; Wokke JH
    Neurology; 1999 Sep; 53(4):837-45. PubMed ID: 10489051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy.
    Bosboom WM; van den Berg LH; Franssen H; Giesbergen PC; Flach HZ; van Putten AM; Veldman H; Wokke JH
    Brain; 2001 Dec; 124(Pt 12):2427-38. PubMed ID: 11701597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical analysis of diabetic patients with chronic inflammatory demyelinating polyradiculoneuropathy].
    Sun QL; Sun AP; Fu Y; Fan DS
    Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):749-752. PubMed ID: 30293336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ataxic form of chronic inflammatory demyelinating polyradiculoneuropathy: clinical features and pathological study of the sural nerves.
    Ohkoshi N; Harada K; Nagata H; Yato M; Shoji S
    Eur Neurol; 2001; 45(4):241-8. PubMed ID: 11385262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The characteristics of chronic inflammatory demyelinating polyneuropathy in patients with and without diabetes--an observational study.
    Dunnigan SK; Ebadi H; Breiner A; Katzberg HD; Barnett C; Perkins BA; Bril V
    PLoS One; 2014; 9(2):e89344. PubMed ID: 24586703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CIDP and other inflammatory neuropathies in diabetes - diagnosis and management.
    Rajabally YA; Stettner M; Kieseier BC; Hartung HP; Malik RA
    Nat Rev Neurol; 2017 Oct; 13(10):599-611. PubMed ID: 28914883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of chronic inflammatory demyelinating polyradiculoneuropathy with and without diabetes mellitus.
    Kalita J; Misra UK; Yadav RK
    Eur J Neurol; 2007 Jun; 14(6):638-43. PubMed ID: 17539941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy.
    Bril V; Blanchette CM; Noone JM; Runken MC; Gelinas D; Russell JW
    J Diabetes Complications; 2016; 30(7):1401-7. PubMed ID: 27389526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy.
    Molenaar DS; Vermeulen M; de Haan R
    J Neurol Neurosurg Psychiatry; 1998 Jan; 64(1):84-9. PubMed ID: 9436733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.